First Time Loading...

Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 7.67 CAD -0.9% Market Closed
Updated: May 15, 2024

Intrinsic Value

Extendicare, Inc. is a holding company, which engages in the provision of nursing care, home health care, retirement living, and management and consulting services. [ Read More ]

The intrinsic value of one EXE stock under the Base Case scenario is 10.37 CAD. Compared to the current market price of 7.67 CAD, Extendicare Inc is Undervalued by 26%.

Key Points:
EXE Intrinsic Value
Base Case
10.37 CAD
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Extendicare Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling EXE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Extendicare Inc

Provide an overview of the primary business activities
of Extendicare Inc.

What unique competitive advantages
does Extendicare Inc hold over its rivals?

What risks and challenges
does Extendicare Inc face in the near future?

Summarize the latest earnings call
of Extendicare Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Extendicare Inc.

Provide P/S
for Extendicare Inc.

Provide P/E
for Extendicare Inc.

Provide P/OCF
for Extendicare Inc.

Provide P/FCFE
for Extendicare Inc.

Provide P/B
for Extendicare Inc.

Provide EV/S
for Extendicare Inc.

Provide EV/GP
for Extendicare Inc.

Provide EV/EBITDA
for Extendicare Inc.

Provide EV/EBIT
for Extendicare Inc.

Provide EV/OCF
for Extendicare Inc.

Provide EV/FCFF
for Extendicare Inc.

Provide EV/IC
for Extendicare Inc.

Show me price targets
for Extendicare Inc made by professional analysts.

What are the Revenue projections
for Extendicare Inc?

How accurate were the past Revenue estimates
for Extendicare Inc?

What are the Net Income projections
for Extendicare Inc?

How accurate were the past Net Income estimates
for Extendicare Inc?

What are the EPS projections
for Extendicare Inc?

How accurate were the past EPS estimates
for Extendicare Inc?

What are the EBIT projections
for Extendicare Inc?

How accurate were the past EBIT estimates
for Extendicare Inc?

Compare the revenue forecasts
for Extendicare Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Extendicare Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Extendicare Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Extendicare Inc compared to its peers.

Compare the P/E ratios
of Extendicare Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Extendicare Inc with its peers.

Analyze the financial leverage
of Extendicare Inc compared to its main competitors.

Show all profitability ratios
for Extendicare Inc.

Provide ROE
for Extendicare Inc.

Provide ROA
for Extendicare Inc.

Provide ROIC
for Extendicare Inc.

Provide ROCE
for Extendicare Inc.

Provide Gross Margin
for Extendicare Inc.

Provide Operating Margin
for Extendicare Inc.

Provide Net Margin
for Extendicare Inc.

Provide FCF Margin
for Extendicare Inc.

Show all solvency ratios
for Extendicare Inc.

Provide D/E Ratio
for Extendicare Inc.

Provide D/A Ratio
for Extendicare Inc.

Provide Interest Coverage Ratio
for Extendicare Inc.

Provide Altman Z-Score Ratio
for Extendicare Inc.

Provide Quick Ratio
for Extendicare Inc.

Provide Current Ratio
for Extendicare Inc.

Provide Cash Ratio
for Extendicare Inc.

What is the historical Revenue growth
over the last 5 years for Extendicare Inc?

What is the historical Net Income growth
over the last 5 years for Extendicare Inc?

What is the current Free Cash Flow
of Extendicare Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Extendicare Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Extendicare Inc

Current Assets 187.1m
Cash & Short-Term Investments 75.2m
Receivables 91m
Other Current Assets 20.9m
Non-Current Assets 485.6m
Long-Term Investments 24.5m
PP&E 295.9m
Intangibles 124.3m
Other Non-Current Assets 40.9m
Current Liabilities 226.4m
Accounts Payable 203.3m
Other Current Liabilities 23.1m
Non-Current Liabilities 358.4m
Long-Term Debt 314.6m
Other Non-Current Liabilities 43.8m
Efficiency

Earnings Waterfall
Extendicare Inc

Revenue
1.3B CAD
Cost of Revenue
-1.2B CAD
Gross Profit
151m CAD
Operating Expenses
-88.1m CAD
Operating Income
63m CAD
Other Expenses
-29m CAD
Net Income
34m CAD

Free Cash Flow Analysis
Extendicare Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

EXE Profitability Score
Profitability Due Diligence

Extendicare Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
53/100
Profitability
Score

Extendicare Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

EXE Solvency Score
Solvency Due Diligence

Extendicare Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
Positive Net Debt
31/100
Solvency
Score

Extendicare Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 8.16 CAD with a low forecast of 7.58 CAD and a high forecast of 8.93 CAD.

Lowest
Price Target
7.58 CAD
1% Downside
Average
Price Target
8.16 CAD
6% Upside
Highest
Price Target
8.93 CAD
16% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

EXE Price
Extendicare Inc

1M 1M
+5%
6M 6M
+19%
1Y 1Y
+5%
3Y 3Y
+9%
5Y 5Y
+27%
10Y 10Y
+99%
Annual Price Range
7.67
52w Low
5.79
52w High
7.88
Price Metrics
Average Annual Return 2.36%
Standard Deviation of Annual Returns 17.29%
Max Drawdown -46%
Shares Statistics
Market Capitalization 637.8m CAD
Shares Outstanding 83 158 315
Percentage of Shares Shorted 3.44%

EXE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Extendicare Inc Logo
Extendicare Inc

Country

Canada

Industry

Health Care

Market Cap

637.8m CAD

Dividend Yield

6.26%

Description

Extendicare, Inc. is a holding company, which engages in the provision of nursing care, home health care, retirement living, and management and consulting services. The company is headquartered in Markham, Ontario. The firm's segments include long-term care, retirement living, home health care, and contract services, consulting and group purchasing as other operations. The company owns and operates 58 long-term care homes with a capacity for 8,138 residents. Under the Esprit Lifestyle Communities brand, it owns and operates approximately 11 retirement communities with 1,050 suites. Through its wholly owned subsidiary ParaMed, its home health care operations provide complex nursing care, occupational, physical and speech therapy, and assistance with daily activities to accommodate those living at home. Through its Extendicare Assist division, it provides contract services and consulting to third parties. Through its SGP Purchasing Partner Network division, it offers purchasing contracts to other senior care providers for food, capital equipment, furnishings, cleaning and nursing supplies, and office products.

Contact

ONTARIO
Markham
3000 Steeles Ave E Suite 700
+19054705534.0
http://www.extendicare.com

IPO

1980-03-17

Employees

23 000

Officers

CEO, President & Director
Dr. Michael R. Guerriere M.D., MBA
Senior VP & CFO
Mr. David E. Bacon
Senior VP, Chief Legal Officer & Corporate Secretary
Mr. John Toffoletto
Chief Medical Officer
Dr. Matthew Morgan
Senior Vice President of ParaMed & CTO
Mr. Steve Paraskevopoulos
VP of Information Technology & Chief Information Officer
Joe Belinsky
Show More
Vice President of Investor Relations
Ms. Jillian E. Fountain
Vice President of Corporate Development
Ms. Kathryn Killoran Bradley
Senior VP & Chief Human Resources Officer
Ms. Katie LeMoyne
Senior Vice President of Long-term Care Operations
Ms. Wendy Gilmour
Show Less

See Also

Discover More
What is the Intrinsic Value of one EXE stock?

The intrinsic value of one EXE stock under the Base Case scenario is 10.37 CAD.

Is EXE stock undervalued or overvalued?

Compared to the current market price of 7.67 CAD, Extendicare Inc is Undervalued by 26%.